COVID-19:Glenmark,アビガン(ファビピラビル)第3相試験:インドで有効性検証(動画): Glenmark begins Phase 3 trials of Favipiravir to check efficacy on COVID-19 in India:  Glenmark开始抗病毒药物Favipiravir的3期试验,以检查其对印度COVID-19患者的疗效

flu, Drugs, Pharmaceutical

COVID-19:仏Alsachim SAS、6種類の分析用試薬発売:血中の薬剤濃度測定(動画):  COVID-19:Alsachim SAS 6 types of analytical reagents: Measuring drug concentration in blood:  COVID-19:法国的Alsachim SAS发行6种分析试剂:测量血液中的药物浓度

flu, Sensor, precision

COVID-19:リトアニア、日本のアビガン臨床試験に参加:100 patients in Lithuania(動画):  Lithuania joins clinical trials for Japanese Covid-19 drug:  立陶宛加入日本Covid-19药物的临床试验

flu, Drugs, Pharmaceutical

COVID-19:露RDIF,アビガン(ファビピラビル)有望な兆候示す:Kirill Dmitriev said(動画):  Russia claims promising signs in early trials of antiviral drug favipiravir Wednesday:  俄罗斯在抗病毒药物favipiravir的早期试验中声称有希望的迹象,星期三,

flu, Drugs, Pharmaceutical

COVID-19:エストニアにアビガン初供与:80カ国近くから要請:  Estonia is the first country to receive Avigan from Japan for research 爱沙尼亚是第一个从日本获得Avigan进行研究的国家

flu, Drugs, Statistics, Pharmaceutical

Posts navigation